As boardroom tussles go, activist Elliott Investment Management’s campaign at RWE looks relatively collegial. The UK arm of ...

Activist investor Elliott (ECAL.UL) on Monday disclosed a stake of close to 5% in RWE , urging the German utility to ...

In a report released today, Javier Garrido from J.P. Morgan maintained a Buy rating on RWE AG (0HA0 – Research Report), with a price target of ...

Elliott Investment Management LP called on RWE AG to ramp up buybacks after amassing a stake of close to 5% in the German utility. RWE has faced intense pressure from investors due to a falling ...

The second term of Donald Trump and last weekend's elections in Germany were high on the agenda this week for the likes of RWE, the German utility giant which is a top-tier player in US renewable ...

Kepler Capital analyst Ingo Becker maintained a Buy rating on RWE AG (0HA0 – Research Report) on March 20 and set a price target of €36.00. The company’s shares closed last Thursday at €32.57.

Increasing interest in real-world evidence (RWE) across all stakeholder groups has the industry buzzing about its current role in clinical trials and the potential impact of expanded use.

Copyright © 2025 MarketWatch, Inc. All rights reserved.